Reducing TRAF4 inhibits proliferation, invasion, and metastasis of breast cancer cells by downregulating the AKT signaling pathway, inactivating the NF-κB path, and engaging the interaction of RSK4 (43). Here, TRAF4 is linked to breast carcinoma.